Key Takeaway: Cancer treatment India for Bangladesh patients offers a lifeline for families facing limited oncology infrastructure at home. With costs 40-60% lower than private treatment in Dhaka, access to proton therapy, immunotherapy, bone marrow transplant, and robotic surgery, and surgery scheduled within 2-4 weeks, thousands of Bangladeshi cancer patients choose cancer treatment India for Bangladesh patients each year. This comprehensive guide covers everything you need to know about cancer treatment India for Bangladesh patients – from costs in Bangladeshi Taka and top hospitals to treatment options and the medical visa process.
Table of Contents
1. Why Bangladeshi Cancer Patients Choose Cancer Treatment India for Bangladesh Patients
Cancer treatment India for Bangladesh patients has become a critical healthcare pathway for thousands of families each year. With limited advanced oncology infrastructure in Bangladesh—only one JCI-accredited hospital in Dhaka—many patients travel to India for comprehensive cancer care including surgery, chemotherapy, radiation, proton therapy, immunotherapy, and bone marrow transplants. The decision to pursue cancer treatment India for Bangladesh patients is often driven by the need for advanced therapies not available at home.
According to the World Health Organisation, cancer is a leading cause of mortality in Bangladesh. Treatment options at home are often limited by:
- Limited availability of advanced radiation therapy (IMRT, IGRT, proton therapy)
- Fewer specialised surgical oncologists
- Limited bone marrow transplant facilities
- Higher costs for private treatment in Dhaka
India offers over 60 JCI-accredited hospitals with comprehensive oncology departments, advanced radiation technology, and experienced multidisciplinary tumour boards. This makes cancer treatment India for Bangladesh patients an increasingly popular and life-saving option. Learn more about global cancer statistics from WHO. For many families, cancer treatment India for Bangladesh patients represents the difference between hope and despair.
For a comprehensive overview of medical travel from Bangladesh, see our guides on medical treatment in India for Bangladesh patients, the best hospital in India for Bangladeshi patients, and Kolkata hospital for Bangladeshi patients.
2. Types of Cancer Treatment Available in India
When considering cancer treatment India for Bangladesh patients, it is important to understand the full range of therapeutic options available. Indian hospitals offer comprehensive, multidisciplinary care tailored to each patient’s specific cancer type and stage. For detailed information on specific therapies, see our guides on chemotherapy, radiation therapy, and immunotherapy.
Surgery
Tumour removal with preservation of healthy tissue. Minimally invasive and robotic techniques are available at leading centres. Surgical oncology departments at top Indian hospitals perform thousands of cancer surgeries annually with outcomes comparable to the best centres globally.
Chemotherapy
Systemic drug therapy to destroy cancer cells. Administered in cycles over weeks or months. National Cancer Institute guidelines are followed in all JCI-accredited Indian hospitals.
Radiation Therapy
External beam (IMRT, IGRT) and internal radiation (brachytherapy) are available. Precise targeting minimises damage to healthy tissue. American Society for Radiation Oncology (ASTRO) standards are adhered to in leading Indian centres.
Targeted Therapy
Drugs that specifically target cancer cell proteins. Used for HER2-positive breast cancer, lung cancer with EGFR mutations, and other molecularly defined cancers.
Immunotherapy
Uses the body’s immune system to fight cancer. Effective for melanoma, lung cancer, and triple-negative breast cancer. Cancer Research Institute protocols are followed in leading Indian centres.
Proton Therapy
Advanced radiation that stops precisely at the tumour, sparing surrounding tissue.
Bone Marrow Transplant
For blood cancers (leukaemia, lymphoma, multiple myeloma) and non-cancerous haematological disorders. Read our complete guide on Bone Marrow Transplant in India.
3. Cancer Treatment Costs in Bangladeshi Taka (BDT)
Understanding the costs of cancer treatment India for Bangladesh patients is essential for planning. The table below provides estimated costs in both USD and Bangladeshi Taka (BDT). Exchange rate: 1 USD ≈ 120 BDT (approximate).
| Treatment | India (USD) | Approximate BDT |
|---|---|---|
| Cancer Surgery | $3,000 – $8,000 | ৳3,60,000 – ৳9,60,000 |
| Chemotherapy (per cycle) | $500 – $2,000 | ৳60,000 – ৳2,40,000 |
| Radiation Therapy (full course) | $2,500 – $6,000 | ৳3,00,000 – ৳7,20,000 |
| Proton Therapy (full course) | $15,000 – $30,000 | ৳18,00,000 – ৳36,00,000 |
| Bone Marrow Transplant | $15,000 – $35,000 | ৳18,00,000 – ৳42,00,000 |
| Full Treatment Course (surgery + chemo + radiation) | $8,000 – $25,000 | ৳9,60,000 – ৳30,00,000 |
Costs vary by cancer type, stage, hospital tier, and treatment protocol. In Bangladesh, private cancer treatment can cost ৳15,00,000 – ৳40,00,000 or more, making India’s costs 40-60% lower even after accounting for travel and accommodation. Contact MedicHorizon for a personalised estimate for cancer treatment India for Bangladesh patients.
4. Breast Cancer Treatment in India
Breast cancer is one of the most common cancers among Bangladeshi women. Cancer treatment India for Bangladesh patients with breast cancer includes surgery (lumpectomy or mastectomy), radiation, chemotherapy, hormone therapy, and targeted therapy. A 2025 study published in Frontiers in Public Health reported 10-year overall survival of 79.0% and 10-year disease-free survival of 76.2% for early-stage breast cancer patients treated in India. The study noted that these survival rates are “better than those reported in Indian cancer registries” and are achievable through comprehensive cancer care.
Indian hospitals offer breast-conserving surgery wherever possible, preserving natural appearance while effectively removing cancer. Oncoplastic breast surgery techniques are available at leading centres, combining cancer removal with cosmetic reconstruction. This comprehensive approach is a key reason why cancer treatment India for Bangladesh patients has such high patient satisfaction rates.
For a complete guide, read our dedicated article on breast cancer treatment in India.
5. Lung Cancer Treatment in India
Lung cancer is a leading cause of cancer mortality in Bangladesh. Cancer treatment India for Bangladesh patients with lung cancer includes surgery, chemotherapy, radiation, targeted therapy, and immunotherapy. Treatment depends on stage and molecular profile, with EGFR and ALK mutation testing guiding targeted therapy decisions.
A 2024 study from a state cancer centre in India reported 2-year overall survival of 74.3% and 3-year overall survival of 70.6% for non-small cell lung cancer patients undergoing surgery with curative intent. A 2025 study on pembrolizumab in advanced non-small cell lung cancer found a median progression-free survival of 10.2 months, with patients receiving combination therapy showing improved outcomes (12.5 months vs. 7.8 months for monotherapy). This evidence supports the effectiveness of cancer treatment India for Bangladesh patients with lung cancer.
Indian hospitals offer video-assisted thoracoscopic surgery (VATS) and robotic lung resections, which are minimally invasive and allow faster recovery. Stereotactic body radiation therapy (SBRT) is available for early-stage lung cancer patients who cannot undergo surgery.
For a complete guide, read our dedicated article on lung cancer treatment in India.
6. Liver Cancer Treatment in India
Liver cancer is common in Bangladesh due to high rates of hepatitis B and C infection. Cancer treatment India for Bangladesh patients with liver cancer includes surgery, liver transplant, TACE (transarterial chemoembolisation), targeted therapy, and immunotherapy.
A 2026 prospective observational cohort study from South India reported that first-line lenvatinib in advanced hepatocellular carcinoma achieved a median overall survival of 13.3 months and progression-free survival of 8.1 months, with non-viral etiology and radiologic response predicting better survival. A 2024 study from North India on atezolizumab and bevacizumab for unresectable hepatocellular carcinoma also demonstrated meaningful activity with manageable toxicity. These findings make cancer treatment India for Bangladesh patients with liver cancer a viable and effective option.
India is a global leader in living donor liver transplantation (LDLT), with survival rates exceeding 90% at one year at leading centres. For patients with early-stage liver cancer who are not candidates for surgery, radiofrequency ablation (RFA) and microwave ablation are available.
For a complete guide, read our dedicated article on liver cancer treatment in India.
7. Prostate Cancer Treatment in India
Prostate cancer is increasingly diagnosed in Bangladeshi men. Cancer treatment India for Bangladesh patients with prostate cancer includes surgery (radical prostatectomy), radiation, hormone therapy, and immunotherapy.
Indian hospitals offer robotic-assisted radical prostatectomy using the Da Vinci surgical system, which provides superior nerve-sparing and faster recovery compared to open surgery. High-intensity focused ultrasound (HIFU) and brachytherapy are available for select patients. This range of options makes cancer treatment India for Bangladesh patients with prostate cancer highly personalised and effective.
For a complete guide, read our dedicated article on prostate cancer treatment in India.
8. Immunotherapy – A Breakthrough Option
Immunotherapy has revolutionised cancer treatment, offering durable responses for patients with melanoma, lung cancer, triple-negative breast cancer, and other malignancies. Cancer treatment India for Bangladesh patients includes access to checkpoint inhibitors (PD-1/PD-L1 inhibitors), CAR-T cell therapy, and cancer vaccines at leading Indian centres.
A 2024 study published in JCO Global Oncology examined immune checkpoint inhibitor use in 100 Indian patients across various tumor types. The study found that adoption of per-body weight and lower dosing of ICIs appears to give acceptable outcomes, and that “lower dosing can improve access and timely delivery of ICIs in low- and middle-income countries.” The study reported a median overall survival of 6.8 months across all dosing groups. This makes cancer treatment India for Bangladesh patients with immunotherapy more accessible than ever.
A 2026 phase III trial (DELII) reported in the Journal of Clinical Oncology concluded that ultra-low-dose nivolumab significantly improves overall survival versus chemotherapy in pretreated solid tumors, with fewer severe toxicities and better quality of life. This has significant implications for resource-constrained settings like Bangladesh, making cancer treatment India for Bangladesh patients an even more attractive option.
For a complete understanding, read our dedicated article on immunotherapy in India.
9. Chemotherapy and Radiation Therapy
Chemotherapy and radiation therapy remain the backbone of cancer treatment for many patients. Cancer treatment India for Bangladesh patients includes access to:
- Intensity-Modulated Radiation Therapy (IMRT): Precisely targets tumours while sparing healthy tissue
- Image-Guided Radiation Therapy (IGRT): Uses imaging to adjust radiation delivery in real-time
- Stereotactic Body Radiation Therapy (SBRT): High-dose radiation for early-stage tumours
- Brachytherapy: Internal radiation for prostate, cervical, and breast cancers
- Neoadjuvant and Adjuvant Chemotherapy: Before and after surgery to improve outcomes
For detailed information, read our guides on chemotherapy and radiation therapy.
10. Bone Marrow Transplant for Bangladeshi Patients
For blood cancers (leukaemia, lymphoma, multiple myeloma) and thalassaemia, bone marrow transplant (BMT) offers a potential cure. Cancer treatment India for Bangladesh patients with haematological conditions often involves BMT at leading Indian centres.
A 2025 study from a BMT unit in India reported that an interdisciplinary team-based approach led to significant improvements: day 100 mortality, hospital acquired infection rate, and antibiotic stewardship reduced by approximately 70% after implementation of the HemeTEAM India program. The program also increased genomics-based testing to 95%, with genetically informed treatment in 65% of patients. These improvements directly benefit cancer treatment India for Bangladesh patients undergoing BMT.
BMT in India costs $15,000–$35,000, compared to $100,000+ in Western countries. This significant cost difference makes cancer treatment India for Bangladesh patients a life-saving option for those requiring BMT.
For a complete guide, read our dedicated article on bone marrow transplant in India.
11. Proton Therapy – Advanced Radiation
Proton therapy is an advanced form of radiation treatment that uses protons rather than X-rays to treat cancer. For Bangladeshi patients seeking the most advanced radiation therapy, proton therapy offers significant advantages. Cancer treatment India for Bangladesh patients includes access to this cutting-edge technology.
A 2025 study on proton therapy for breast cancer patients in India reported encouraging results, with the technique effectively reducing heart and cardiac substructure doses – particularly important given that “Indians have a higher incidence of cardiovascular diseases, often at a younger age, than other ethnic groups.” Early experience with image-guided pencil beam scanning proton therapy for craniopharyngioma in India showed that treatment was “well tolerated, resulting in limited toxicity and promising early outcomes.” This makes cancer treatment India for Bangladesh patients with proton therapy a safe and effective option.
It is particularly relevant for:
- Paediatric cancers: Spares developing tissue, reducing long-term side effects
- Brain and spinal tumours: Near critical structures where precision is essential
- Head and neck cancers: Where sparing salivary glands and swallowing function matters
- Recurrent cancers: Requiring re-irradiation where conventional radiation may not be safe
A 2024 article discussed the “emerging role of modern proton therapy in India,” noting that proton beam therapy has “shown potential in minimizing the side effects of radiation treatment, including radiation-induced second cancers.” For families seeking cancer treatment India for Bangladesh patients, proton therapy represents the pinnacle of radiation oncology.
12. Top Cancer Hospitals in India for Bangladeshi Patients
When seeking cancer treatment India for Bangladesh patients, choosing the right hospital is critical. Below are some of the top cancer hospitals that regularly treat international patients from Bangladesh.
Delhi NCR
- Indraprastha Apollo Hospital, New Delhi – Comprehensive oncology, 2,500+ robotic procedures, JCI accredited
- BLK-Max Super Speciality Hospital, New Delhi – Leading BMT and haematology unit, NABH accredited
- Max Super Speciality Hospital, Saket, New Delhi – NABH accredited, advanced radiation
Chennai
- Gleneagles Global Health City, Chennai – Multi-organ transplant, comprehensive oncology, JCI accredited
- Sri Ramachandra Medical Centre, Chennai – University-led research hospital, NABH accredited
Mumbai
- Kokilaben Dhirubhai Ambani Hospital, Mumbai – Advanced radiation and surgical oncology, JCI accredited
- Tata Memorial Hospital, Mumbai – Government-funded, highly subsidised rates for Indian citizens; international patients can access private wings
Bangalore
- Fortis Hospital, Bangalore – Comprehensive cancer care, NABH accredited
- Manipal Hospitals, Bangalore – Advanced radiation therapy, JCI accredited
These hospitals are equipped with state-of-the-art technology, employ experienced oncologists, and have successfully treated thousands of international patients, including many from Bangladesh. All institutions in the MedicHorizon network hold international accreditations (NABH/JCI), ensuring you receive care that meets the highest global standards of safety and clinical excellence for cancer treatment India for Bangladesh patients.
13. Medical Visa Process for Cancer Patients
Bangladeshi cancer patients require a Medical Visa (MED) for cancer treatment India for Bangladesh patients. Requirements include:
- Passport with 6 months validity and 2 blank pages
- Medical reports from a recognised hospital in Bangladesh
- Hospital appointment letter from the treating Indian hospital (MedicHorizon coordinates this)
- Proof of financial means to cover treatment and stay (USD 150+ per applicant)
- Passport-sized photographs
- National ID or Birth Certificate copy
- Proof of residence (utility bill)
Processing time: 5–10 working days. For long treatment courses, multiple-entry visas may be available. MedicHorizon coordinates hospital invitation letters and assists with the visa application process for cancer treatment India for Bangladesh patients.
For detailed guides on the visa process, read our articles on medical visa India from Dhaka process and Indian medical visa for Bangladesh.
14. Frequently Asked Questions
How long does cancer treatment take in India?
Varies by type and stage. Surgery: 1–2 weeks in India. Chemotherapy: multiple cycles over 3–6 months, with travel back and forth. Radiation: 4–7 weeks daily. Some patients stay in India for the full course; others travel for each cycle. Your oncologist will provide a personalised treatment timeline for your cancer treatment India for Bangladesh patients journey.
Is proton therapy available for Bangladeshi patients?
Yes. Proton therapy is available in India, with early experience showing it is “well tolerated, resulting in limited toxicity and promising early outcomes.” A medical visa and hospital appointment are required. Proton therapy is particularly beneficial for paediatric and brain cancers, making it a valuable option for cancer treatment India for Bangladesh patients.
Can I get a second opinion before starting treatment?
Yes. MedicHorizon coordinates video consultations with Indian oncologists before you travel. Tumour board reviews are available at major hospitals, providing multidisciplinary input from surgical, medical, and radiation oncologists. This is an important first step in cancer treatment India for Bangladesh patients.
What is the success rate of cancer treatment in India?
Success rates depend on cancer type and stage. A 2025 study reported 10-year overall survival of 79.0% for early-stage breast cancer patients in India. Lung cancer surgery studies report 2-year overall survival of 74.3% and 3-year overall survival of 70.6%. These outcomes support the effectiveness of cancer treatment India for Bangladesh patients.
Can family members accompany the patient?
Yes. Medical visas typically allow one attendant per patient. Additional family members may apply for tourist visas. MedicHorizon can assist with accommodation for family members during cancer treatment India for Bangladesh patients.
How much does cancer treatment cost in India compared to Bangladesh?
Cancer treatment costs in India are 40-60% lower than private treatment in Bangladesh. For complex cancers requiring proton therapy or BMT, India may be the only accessible option in the region. Full treatment courses in India cost $8,000–$25,000 compared to significantly higher costs in Dhaka. This cost advantage is a key reason for choosing cancer treatment India for Bangladesh patients.
15. How MedicHorizon Assists Bangladeshi Patients
MedicHorizon provides coordination and support — not medical advice. We help Bangladeshi patients find the right cancer hospital and oncologist for cancer treatment India for Bangladesh patients based on their cancer type, stage, and budget.
Hospital Selection
We connect you with the right JCI-accredited cancer hospital and specialist for your specific cancer type. Finding the best hospital in India for Bangladeshi patients is our specialty.
Tumour Board Coordination
We arrange multidisciplinary case review before you travel, ensuring your treatment plan is comprehensive and evidence-based for your cancer treatment India for Bangladesh patients journey.
Video Consultations
We connect you with Indian oncologists before arrival, allowing you to make an informed decision without leaving Bangladesh.
Visa Documentation
We provide hospital invitation letters for your medical visa application and advise on current processing timelines. Read our guides on medical visa India from Dhaka process and Indian medical visa for Bangladesh.
Travel & Accommodation
We assist with flights, accommodation, and airport transfers, ensuring your journey is stress-free.
Bengali-Speaking Coordination
Our team includes Bengali-speaking coordinators to assist you throughout your journey – from first contact to return home. For personalised concierge support, read our guide on medical concierge India for Bangladeshi patients.
Cost Estimates
We provide transparent, all-inclusive cost estimates in Bangladeshi Taka with no hidden fees.
Post-Treatment Follow-Up
We arrange teleconsultations with your Indian oncologist after you return to Bangladesh – at 3, 6, and 12 months.
Important: MedicHorizon does not provide medical advice, guarantee treatment outcomes, or assume responsibility for the clinical services rendered by the treating hospital. All medical decisions are solely between you and your licensed physicians. The hospital bill is payable directly to the hospital; our charges cover only the coordination and hospitality services described above.
📧 Email: contactmedichorizon@gmail.com
🌐 Website: MedicHorizon Hospital Directory
Legal Disclaimer
This article is for general informational and educational purposes only. MedicHorizon is a health hospitality consultancy, not a medical provider, hospital, or licensed medical practitioner. We do not diagnose, treat, prescribe, or offer medical opinions. All information regarding cancer treatment India for Bangladesh patients is based on publicly available data and does not constitute medical advice. You should independently verify all information and consult with qualified healthcare professionals before making any treatment decisions. Any medical procedure carries inherent risks. By using our services, you acknowledge that all medical decisions remain solely your responsibility.